Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 1.0T | 1.2T | 1.2T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 169.3B | 162.1B | 163.9B |
Other operating expenses | — | 173.9B | 1.4B | 1.4B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 3.3B | 3.6B | 3.5B |
Other income expense | — | 74.0B | 70.3B | 57.3B |
Pretax income | — | 52.1B | 249.1B | 51.2B |
Tax provision | — | -40.1B | 56.2B | 19.2B |
Net income | — | 92.2B | 192.9B | 32.0B |
Basic EPS | 121.5 | — | — | — |
Diluted EPS | 121.5 | — | — | — |
Basic average shares | 987.7M | — | — | — |
Diluted average shares | 987.7M | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | 808M | -1.3B | -551M |
Preferred stock dividends | — | — | — | — |